CONTURA ORTHOPAEDICS LIMITED
Get an alert when CONTURA ORTHOPAEDICS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£735k
+154% vs 2024
Net assets
-£343k
+78.6% vs 2024
Employees
14
+55.6% vs 2024
Profit before tax
£1.2m
+248.5% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £5,632,538 | £11,562,810 | +105.3% | |
| Operating profit | -£834,694 | £1,276,222 | +252.9% | |
| Profit before tax | -£838,351 | £1,244,874 | +248.5% | |
| Net profit | -£838,351 | £1,244,591 | +248.5% | |
| Cash | £289,559 | £735,468 | +154% | |
| Total assets less current liabilities | -£1,601,501 | -£343,176 | +78.6% | |
| Net assets | -£1,601,501 | -£343,176 | +78.6% | |
| Equity | -£1,601,501 | -£343,176 | +78.6% | |
| Average employees | 9 | 14 | +55.6% | |
| Wages | £1,075,361 | £1,874,381 | +74.3% | |
| Directors' remuneration | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating margin | -14.8% | 11.0% | |
| Net margin | -14.9% | 10.8% | |
| Gearing (liabilities / total assets) | 129.5% | 102.9% | |
| Current ratio | 0.44x | 0.74x | |
| Interest cover | — | 39.56x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- MHA
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have reviewed the financial forecasts of the Group and stress tested them to consider all likely scenarios. The directors ... have confirmed that they will provide financial support, as required, for the foreseeable future.”
Group structure
- CONTURA ORTHOPAEDICS LIMITED · parent
- Speciality European Pharma Italy S.r.l. 100%
- Contura Orthopedics (Canada) Limited 100%
Significant events
- “On 26 February 2026, the U.S. Food and Drug Administration's (FDA) Office of Combination Products (OCP) determined that Arthrosamid should be regulated as a medical device.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 0 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BANKS, Patrick John | Secretary | 2021-01-07 | — | — |
| BANKS, Patrick John | Director | 2021-01-07 | Aug 1962 | British |
| FRASER-PYE, Graham Julian | Director | 2021-01-07 | Mar 1968 | British |
| JACOBSON, Ian | Director | 2021-01-07 | Mar 1960 | Canadian |
| PODOLSKY, Craig | Director | 2021-01-07 | Feb 1981 | Canadian |
| TAILOR, Rakesh Chhaganlal | Director | 2021-01-07 | Mar 1974 | British |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Juno Pharmaceuticals Lp | Corporate entity | Shares 50–75%, Voting 50–75% | 2021-03-01 | Active |
| Contura Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-01-07 | Ceased 2021-03-01 |
Filing timeline
Last 19 of 19 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-04-28 MA Memorandum articles
- 2022-04-27 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-10-12 | AA | accounts | Accounts with accounts type group | |
| 2026-03-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-01-08 | AA | accounts | Accounts with accounts type small | |
| 2025-03-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-01-31 | AA | accounts | Accounts with accounts type small | |
| 2024-02-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-10 | AA | accounts | Accounts with accounts type small | |
| 2023-01-30 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-01-17 | AA | accounts | Accounts with accounts type small | |
| 2022-11-03 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2022-04-28 | MA | incorporation | Memorandum articles | |
| 2022-04-27 | RESOLUTIONS | resolution | Resolution | |
| 2022-04-26 | SH01 | capital | Capital allotment shares | |
| 2022-02-15 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2022-02-15 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2022-02-15 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2021-03-04 | SH01 | capital | Capital allotment shares | |
| 2021-01-07 | AA01 | accounts | Change account reference date company current shortened | |
| 2021-01-07 | NEWINC | incorporation | Incorporation company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 3
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.